Benjamin G Trist,Sian Genoud,Stéphane Roudeau,Alexander Rookyard,Amr Abdeen,Veronica Cottam,Dominic J Hare,Melanie White,Jens Altvater,Jennifer A Fifita,Alison Hogan,Natalie Grima,Ian P Blair,Kai Kysenius,Peter J Crouch,Asuncion Carmona,Yann Rufin,Stéphane Claverol,Stijn Van Malderen,Gerald Falkenberg,David J Paterson,Bradley Smith,Claire Troakes,Caroline Vance,Christopher E Shaw,Safa Al-Sarraj,Stuart Cordwell,Glenda Halliday,Richard Ortega,Kay L Double

Abstract:Abstract Aberrant self-assembly and toxicity of wild-type and mutant superoxide dismutase 1 (SOD1) has been widely examined in silico, in vitro and in transgenic animal models of amyotrophic lateral sclerosis. Detailed examination of the protein in disease-affected tissues from amyotrophic lateral sclerosis patients, however, remains scarce. We used histological, biochemical and analytical techniques to profile alterations to SOD1 protein deposition, subcellular localization, maturation and post-translational modification in post-mortem spinal cord tissues from amyotrophic lateral sclerosis cases and controls. Tissues were dissected into ventral and dorsal spinal cord grey matter to assess the specificity of alterations within regions of motor neuron degeneration. We provide evidence of the mislocalization and accumulation of structurally disordered, immature SOD1 protein conformers in spinal cord motor neurons of SOD1-linked and non-SOD1-linked familial amyotrophic lateral sclerosis cases, and sporadic amyotrophic lateral sclerosis cases, compared with control motor neurons. These changes were collectively associated with instability and mismetallation of enzymatically active SOD1 dimers, as well as alterations to SOD1 post-translational modifications and molecular chaperones governing SOD1 maturation. Atypical changes to SOD1 protein were largely restricted to regions of neurodegeneration in amyotrophic lateral sclerosis cases, and clearly differentiated all forms of amyotrophic lateral sclerosis from controls. Substantial heterogeneity in the presence of these changes was also observed between amyotrophic lateral sclerosis cases. Our data demonstrate that varying forms of SOD1 proteinopathy are a common feature of all forms of amyotrophic lateral sclerosis, and support the presence of one or more convergent biochemical pathways leading to SOD1 proteinopathy in amyotrophic lateral sclerosis. Most of these alterations are specific to regions of neurodegeneration, and may therefore constitute valid targets for therapeutic development.

Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction

SOD1 exhibits allosteric frustration to facilitate metal binding affinity

Mechanical Probes of SOD1 Predict Systematic Trends in Metal and Dimer Affinity of ALS-Associated Mutants

Amyotrophic-Lateral-Sclerosis and Structural Defects in Cu,Zn Superoxide-Dismutase

Folding of Cu, Zn superoxide dismutase and Familial Amyotrophic Lateral Sclerosis

Cupric Ions Induce The Oxidation And Trigger The Aggregation Of Human Superoxide Dismutase 1

Exon 5 Encoded Domain is Not Required for the Toxic Function of Mutant SOD1 but Essential for the Dismutase Activity: Identification and Characterization of Two New SOD1 Mutations Associated with Familial Amyotrophic Lateral Sclerosis

Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria.

Oxidative Modification of Cysteine 111 Promotes Disulfide Bond-Independent Aggregation of SOD1

Unfolding and aggregation of oxidized metal-deficient superoxide dismutase and isoflavone inhibition based on ion mobility mass spectrometry and ThT fluorescence assay

Mutation/metal deficiency in the "electrostatic loop" enhanced aggregation process in apo/holo SOD1 variants: implications for ALS diseases

Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions

Heat-shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide dismutase: clues to a possible strategy for treating ALS

Nonamyloid Aggregates Arising from Mature Copper/Zinc Superoxide Dismutases Resemble Those Observed in Amyotrophic Lateral Sclerosis

Implications of ALS-Associated Mutations on Biochemical and Biophysical Features of hSOD1 and Aggregation Formation

Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord

Mass spectrometry imaging of SOD1 protein-metal complexes in SOD1G93A transgenic mice implicates demetalation with pathology

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Pathological hydrogen peroxide triggers the fibrillization of wild-type SOD1 via sulfenic acid modification of Cys-111

High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation